Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling

Annals of the New York Academy of Sciences

Volumn 861, Issue , 1998, Pages 183-189

  Thomas, E A ^a   Carson, M J ^a   Sutcliffe, J G ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; CYCLIC AMP; OLEAMIDE; RECEPTOR SUBTYPE; SEROTONIN 2A RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL CELL; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HYPOPHYSIS CELL; MAMMAL CELL; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

ANIMALIA; FELIS CATUS; MAMMALIA;

EID: 0032417599     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10190.x     Document Type: Conference Paper

References (26)

1. 1. DEVANE, W. A., L. HANUS, A. BREUER, R. G. PERTWEE, L. A. STEVENSON, G. GRIFFIN, D. GIBSON, A. MANDELBAUM, A. ETINGER & R. MECHOULAM. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949.
2. 2. ARAFAT, E. S., J. W. TRIMBLE, R. N. ANDERSEN, C. DASS & D. M. DESIDERIO. 1989. Identification of fatty acid amides in human plasma. Life Sci. 45: 1679-1687.
3. 3. CRAVATT, B. F., O. PROSPERO-GARCIA, G. SIUZDAK, N. B. GILULA, S. J. HENRIKSEN, D. L. BOGER & R. A. LERNER. 1995. Chemical characterization of a family of brain lipids that induce sleep. Science 268: 1506-1509.
4. 4. GUAN, X., B. F. CRAVATT, G. R. EHRING, J. E. HALL, D. L. BOGER, R. A. LERNER & N. B. GILULA. 1997. The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells. Cell Biol. 139: 1785-1792.
5. 5. HUIDOBRO-TORO, J. P. & R. A. HARRIS. 1996. Brain lipids that induce sleep are novel modulators of 5-hydroxytryptamine receptors. Proc. Natl. Acad. Sci. USA 93: 8078-8082.
6. 6. RAIBLE, D. W. & F. A. MCMORRIS. 1990. Induction of oligodendrocyte differentiation by activators of adenylate cyclase. J. Neurosci. Res. 27: 43-46.
7. 7. IVINS, K. J. & P. B. MOLINOFF. 1990. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line. Mol. Pharmacol. 37: 622-630.
8. 8. LOVENBERG, T. W., B. M. BARON, L. DE LECEA, J. D. MILLER, R. A. PROSSER, M. A. RHEA, P. E. FOYE, M. RACKE, A. L. SLONE, B. W. SIEGEL, P. E. DANIELSON, J. G. SUTCLIFFE & M. G. ERLANDER. 1993. A novel adenylyl cyclase-activating serotonin receptor (5HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11: 449-458.
9. 9. THOMAS, E. A., S. B. BAKER & F. J. EHLERT. 1993. Functional role for the M2 muscarinic receptor in smooth muscle of the ileum. Mol. Pharmacol. 44: 102-110.
10. 10. MANZONI, O., L. FAGNI, J. P. PIN, F. RASSENDREN, F. POULAT, F. SLADECSEK & J. BOCKAERT. 1990. (trans)-1-amino-cyclopentyl-1,3-dicarboxylate stimulates quisqualate phosphoinositide-coupled receptors but not ionotropic glutamate receptors in striatal neurons and Xenopus oocytes. Mol. Pharmacol. 38: 1-6.
11. 11. SAXENA, P. R. 1995. Serotonin receptors: Subtypes, functional responses and therapeutic relevance. Pharmacol. & Ther. 66: 339-368.
12. 12. KOSCHEL, K. 1980. A hormone-independent rise of adenosine 3′,5′-monophosphate desensitizes coupling of beta-adrenergic receptors to adenylate cyclase in rat glioma C6-cells. Eur. J. Biochem. 108: 163-169.
13. 13. SHI, Q. H., J. A. RUIZ & R. J. HO. 1986. Forms of adenylate cyclase, activation and/or potentiation by forskolin. Arch. Biochem. Biophys. 251: 156-165.
14. 14. FRENKEN, M. & A. J. KAUMANN. 1987. Interconversion into a low active state protects vascular 5-HT2-receptors against irreversible antagonism by phenoxybenzamine. Naunyn-Schmiedebergs Arch. Pharmacol. 335: 359-366.
15. 7) positively linked to adenylate cyclase. J. Biol. Chem. 268: 23422-23426.
16. 2 receptor: Identification of amino acids necessary for ligand binding and receptor activation. Mol. Pharmacol. 43: 931-940.
17. 17. KIZER, J. S., W. H. JR. BUSBY, C. COTTLE & W. W. YOUNGBLOOD. 1984. Glycine-directed peptide amidation: presence in rat brain of two enzymes that convert p-Glu-His-Pro-Gly-OH into p-Glu-His-Pro-NH2 (thyrotropin-releasing hormone). Proc. Natl. Acad. Sci. USA. 81: 3228-3232.
18. 18. REYNOLDS, I. J. & R. J. MILLER. 1990. Allosteric modulation of N-methyl-D-aspartate receptors. Adv. Pharmacol. 21: 101-126.
19. 19. WISDEN, W. & P. H. SEEBURG. 1992. GABAA receptor channels: From subunits to functional entities. Curr. Opin. Neurobiol. 2: 263-269.
20. 20. DEUTSCH, S. I., J. MASTROPAOLO & A. HITRI. 1992. GABA-active steroids: Endogenous modulators of GABA-gated chloride ion conductance. Clin. Neuropharmacol. 15: 352-364.
21. 21. COSTA, E. 1989. Allosteric modulatory centers of transmitter amino acid receptors. Neuropharmacology 2: 167-174.
22. 22. JAKUBIK, J. & S. TUCEK. 1994. Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium. J. Neurochem. 63: 1932-1940.
23. 23. LEE, N. H. & E. E. EL-FAKAHANY. 1991. Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem. Pharmacol. 42: 199-205.
24. 24. Xu, Z. & R. E. PURDY. 1989. Evidence for allosteric blockade of serotonergic receptors in rabbit thoracic aorta. J. Pharmacol. Exp. Ther. 248: 101-1095.
25. 25. HOWARD, M. J., R. J. HUGHES, H. J. MOTULSKY, M. D. MULLEN & P. A. INSEL. 1987. Interactions of amiloride with alpha- and beta-adrenergic receptors: Amiloride reveals an allosteric site on alpha 2-adrenergic receptors. Mol. Pharmacol. 32: 53-58.
26. 26. JAKUBIK, J., L. BACAKOVE, V. LISA, E. E. EL-FAKAHANY & S. TUCEK. 1996. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc. Natl. Acad. Sci. USA 93: 8705-8709.